US Stock MarketDetailed Quotes

BBLG Bone Biologics

Watchlist
  • 1.2000
  • -0.0100-0.83%
Close Dec 4 16:00 ET
2.96MMarket Cap-342P/E (TTM)

About Bone Biologics Company

Bone Biologics Corp. operates as a medical device company. engages in the research and development of bone regeneration in spinal fusion. Its product is Nell-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. Its platform technology has application in delivering improved outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company was founded by Eric Kang Ting, Chia Soo and Benjamin Wu in 2004 and is headquartered in Burlington, MA.

Company Profile

SymbolBBLG
Company NameBone Biologics
Listing DateOct 13, 2021
Founded2004
CEOMr. Jeffrey Frelick
MarketNASDAQ
Employees2
Fiscal Year Ends12-31
Address2 Burlington Woods Drive,Suite 100
CityBurlington
ProvinceMassachusetts
CountryUnited States of America
Zip Code01803
Phone1-781-552-4452

Company Executives

  • Name
  • Position
  • Salary
  • Jeffrey Frelick
  • Chief Executive Officer and President
  • 376.60K
  • Deina H. Walsh
  • Chief Financial Officer and Principal Accounting Officer
  • 238.30K
  • Robert Gagnon, M.B.A.
  • Director
  • --
  • Phillip Terry Meikle
  • Director
  • --
  • Siddhesh R. Angle
  • Independent Director
  • 76.88K
  • Bruce Stroever
  • Independent Director
  • 76.88K